News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ramius Goes Hostile for Cypress Bioscience Inc. (CYPB) with Sweetened Bid


9/15/2010 8:29:23 AM

Sept 15 (Reuters) - Hedge fund Ramius LLC took a sweetened $164 million cash bid for Cypress Bioscience Inc (CYPB.O) directly to the U.S. drugmaker's shareholders after the company rejected its previous bid in August.

Read at Wall Street Journal
Read at Market Watch
Read at Reuters

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES